v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Apr. 30, 2026
Jul. 31, 2025
Current assets    
Cash and cash equivalents $ 983,000 $ 334,000
Accounts receivable 242,000 474,000
Inventories, net 232,000 141,000
Restricted cash 75,000 75,000
Prepaid expenses 17,000 23,000
Total current assets 1,549,000 1,047,000
Property, plant and equipment, net 9,000 11,000
Total assets 1,558,000 1,058,000
Current liabilities    
Accounts payable 719,000 784,000
Convertible notes payable to related parties, current 2,754,000
Accrued liabilities 181,000 154,000
Total current liabilities 3,654,000 938,000
Convertible notes payable to related parties, non-current 3,743,000 5,236,000
Total liabilities 7,397,000 6,174,000
Commitments and contingencies  
Stockholders’ deficiency    
Preferred stock, $0.01 par value: 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.01 par value: 200,000,000 shares authorized, 130,017,569 shares issued and outstanding at April 30, 2026, and 111,886,473 at July 31, 2025 1,301,000 1,119,000
Additional paid-in capital 133,727,000 132,759,000
Accumulated deficit (140,867,000) (138,994,000)
Total stockholders’ deficiency (5,839,000) (5,116,000)
Total liabilities and stockholders’ deficiency $ 1,558,000 $ 1,058,000